CSL Seqirus announces Lancet publication on influenza vaccine
CSL Seqirus said a Phase 3 study was published in The Lancet showing benefits for older adults from a first influenza vaccine combining three proven approaches.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.